Facebook comment sections rife with misinformation following Pfizer’s Covid-19 antiviral pill announcement
First Draft uses cookies to distinguish you from other users of our website. They allow us to recognise users over multiple visits, and to collect basic data about your use of the website. Cookies help us provide you with a good experience when you browse our website and also allows us to improve our site. Check our cookie policy to read more. Cookie Policy.

This website is hosted in perpetuity by the Internet Archive.

Facebook comment sections rife with misinformation following Pfizer’s Covid-19 antiviral pill announcement

Medicine pills are seen with Pfizer logo displayed on a screen in the background in this illustration photo
Pfizer is developing an experimental Covid-19 antiviral pill, Paxlovid, which has been met with misinformation. (Photo Illustration by Jakub Porzycki/NurPhoto)

Last week Pfizer published interim trial results for its experimental Covid-19 antiviral pill, Paxlovid, which the company said reduced the chance of hospitalization or death for some adults by almost 90 per cent. The US pharmaceutical giant’s analysis included 1,219 adults who had been diagnosed with mild to moderate Covid-19 and who had at least one risk factor for developing severe disease.

First Draft examined Facebook posts by Australian news publishers covering this story and found that misinformation and misunderstandings flourished in the comment sections, with potential audiences in the hundreds of thousands over the past week.

Facebook users questioned the efficacy and relevance of Covid-19 vaccines in light of the emergence of the antiviral pill, questioning the need for the pill if the vaccine is effective. Others shared the misleading claim that the Covid-19 vaccines are as not effective as reported if a pill could cure the disease or alleviate the condition.  While the antiviral pill may be helpful for those diagnosed with Covid-19, vaccines reduce a person’s chances of contracting it.

Many commenters incorrectly drew links with the anti-parasitic medication ivermectin, describing the Pfizer antiviral treatment as “Ivermectin renamed,” “like ivermectin but more expensive” and “Pfizermectin.” The comment sections became a forum for the misleading promotion of ivermectin as a “safe and effective,” “tried and tested” and “successful” treatment for Covid-19.

The antiviral pill and ivermectin are not the same. The WHO recommends against using ivermectin in patients with Covid-19, except in the context of a clinical trial. Misinformation around ivermectin as a Covid-19 treatment has led to real-world harm.

Negative sentiments about profits to be made from the medication were also common, with comments speculating this is a new stream of revenue for Pfizer after making the vaccines.

First Draft reported on similar narratives circulating in October after the Merck antiviral pill molnupiravir was approved in the UK. Explainer stories and prebunks addressing the respective roles of Covid-19 vaccines and treatments could prevent data deficits that lead to the spread of misinformation.

Discussions taking place in comment sections have the potential to shape attitudes and behaviors. Previous First Draft research has highlighted a need for greater content moderation by publishers as well as the gap between Facebook’s misinformation policies and actual outcomes. — Lucinda Beaman

Leave a Reply

This article is from our daily briefing email newsletter. Subscribe for the key stories caught by our monitoring team each day, and be sure to check out our weekly briefing the best misinformation reads.

A roundup of the latest and most important misinformation narratives that you need to know about each day.

A weekly review of the best misinformation reads and talking points from around the world.

News from First Draft and invitations to all of our training and events.